Lung cancer is the most commonly occurring cancer in men and the third most commonly
occurring cancer in women. Contrary to other cancers, lung cancer often occurs in patients …

Stereotactic body radiation therapy (SBRT) allows for the non-invasive and precise delivery
of ablative radiation dose. The use and availability of SBRT has increased rapidly over the …

Stereotactic body radiotherapy (SBRT) was first described in the mid 90s as a technique
using high precision radiotherapy to deliver escalated, ablative irradiation doses and which …

Lung neoplasm is the most influent cause of death for cancer. With the increasing of life
expectancy in elderly patients and with the intensification of lung cancer screening by low …

Stereotactic body radiotherapy (SBRT), also known as stereotactic ablative radiotherapy, is
characterised as a highly noninvasive precise radiotherapy that is performed by applying an …

Stereotactic body radiotherapy (SBRT) represents a consolidated treatment option for
patients with medically inoperable early stage non-small cell lung cancer (NSCLC). The …

Patients affected with early stage (IA–IB) non-small cell lung cancer (NSCLC), deemed
medically inoperable, are usually treated by conventional 3D-CRT, with poor results in terms …

This report from the Stereotactic Radiotherapy Working Group of the German Society of
Radiation Oncology (Deutschen Gesellschaft für Radioonkologie, DEGRO) provides a …

Clinical use of stereotactic body radiation therapy (SBRT) has increased dramatically over
the last 2 decades and is the current standard-of-care in cases of inoperable early stage non …

Stereotactic ablative body radiotherapy (SABR) describes a radiotherapy (RT) technique
where high doses of radiation are precisely delivered to an extracranial target within the …